GAPDH Antikörper (C-Term)

Produktnummer ABIN1440020

Der Ziege Polyklonal Anti-GAPDH-Antikörper wurde für WB, IF, IHC (p) und IHC (fro) validiert. Er ist geeignet, GAPDH in Proben von Human, Maus, Ratte, Kaninchen, Schwein, Huhn, Hund, Affe, Schaf, Rind (Kuh), Hamster, Cat, Pferd, Meerschweinchen, Ziege, Avian und Esel zu detektieren. Es sind 4+ Publikationen verfügbar.

Kurzübersicht für GAPDH Antikörper (C-Term) (ABIN1440020)

Target: GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))

Reaktivität: Human, Maus, Ratte, Kaninchen, Schwein, Huhn, Hund, Affe, Schaf, Rind (Kuh), Hamster, Cat, Pferd, Meerschweinchen, Ziege, Avian, Esel

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser GAPDH Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktdetails anti-GAPDH Antikörper

Bindungsspezifität: C-Term

Spezifität: Detects a band of 37 kDa by Western blot in the following human (293A, HMEC-1, U-118, HaCat), rat (TR-iBRB), mouse (AtT-20, Hepa), canine (D17) and monkey (COS-7) whole cell lysates.

Produktmerkmale: Glyceraldehyde-3-phosphate dehydrogenase

Aufreinigung: epitope affinity purified

Immunogen: Purified recombinant peptide derived from within residues 240 aa to the C-terminus of human GAPDH produced in E. coli.

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 2 mg/mL

Buffer: Polyclonal antibody supplied as a 200 µL (2 mg/mL) aliquot in PBS, 20 % glycerol and 0.05 % sodium azide

Handhabung: The antibody solution should be gently mixed before use.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: For continuous use, store at 2-8 deg,C for one-two days. For extended storage, store in -20 deg,C freezer. Working dilution samples should be discarded if not used within 12 hours.

Referenzen für anti-GAPDH Antikörper (ABIN1440020)

Khalafalla, Kayani, Kassab, Ilves, Monsanto, Alvarez, Chavarria, Norman, Dembitsky, Sussman: "Empowering human cardiac progenitor cells by P2Y14 nucleotide receptor overexpression." in: The Journal of physiology, Vol. 595, Issue 23, pp. 7135-7148, (2018) (PubMed).

Gonçalves, Lin, Muthusamy, Fontes-Ribeiro, Ambrósio, Abcouwer, Fernandes, Antonetti: "Protective Effect of a GLP-1 Analog on Ischemia-Reperfusion Induced Blood-Retinal Barrier Breakdown and Inflammation." in: Investigative ophthalmology & visual science, Vol. 57, Issue 6, pp. 2584-92, (2017) (PubMed).

Hyenne, Apaydin, Rodriguez, Spiegelhalter, Hoff-Yoessle, Diem, Tak, Lefebvre, Schwab, Goetz, Labouesse: "RAL-1 controls multivesicular body biogenesis and exosome secretion." in: The Journal of cell biology, Vol. 211, Issue 1, pp. 27-37, (2016) (PubMed).

Helsby, Leader, Fenn, Gulsen, Bryant, Doughton, Sharpe, Whitley, Caunt, James, Pope, Kelly, Chalmers: "CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited." in: BMC cell biology, Vol. 15, pp. 6, (2014) (PubMed).

Details zu GAPDH

Target: GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))

Andere Bezeichnung: GAPDH

Hintergrund: GAPDH catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The enzyme exists as a tetramer of identical chains.
Synonyms: glyceraldehyde 3-phosphate dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase, G3PD, GAPD, HGNC:4141, GAPDH antibody.
Ensembl identifier: ENSG00000111640